CPH 0.00% 0.9¢ creso pharma limited

Ann: Quarterly Activities Report & Appendix 4C, page-9

  1. 2,096 Posts.
    lightbulb Created with Sketch. 575
    I did a compare of the following

    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8
    0 {colgroup}
    1 {col=100x@}{/col}{col=100x@}{/col}{col=100x@}{/col}{col=100x@}{/col}{col=100x@}{/col}{col=100x@}{/col}{col=100x@}{/col}{col=100x@}{/col}
    2 {/colgroup}
    3 MXC MMJ CPH

    ZLD AC8 EXL CAN BOT

    Points of interest:
    - third biggest spender for the quarter
    - looking to be third biggest spender next quarter (2M Mernova production facility)
    - midrange/average burn rate looking to spend 25% of available cash/cash equivalences on hand.
    - the second in the number of receipts from customers
    - midrange / average staff overhead costs.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.